Pharmaceutical Antitrust: Unilateral Conduct
In the pharmaceutical sector, unilateral conduct can lead to antitrust liability if a firm uses exclusionary practices to maintain monopoly power or fails to uphold responsibility to ensure fair competition. In this video, Gregory Luib, Marion Provost and Mélanie Thill-Tayara explore various types of infringement in both the U.S. and EU, the question of exploitative abuse as well as notable court cases involving monopoly or dominance-related offenses.